Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMICIZUMAB vs EMPAGLIFLOZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMICIZUMAB vs EMPAGLIFLOZIN: Safety Overview

Metric EMICIZUMAB EMPAGLIFLOZIN
Total FAERS Reports 733 37,059
Deaths Reported 42 1,624
Death Rate 5.7% 4.4%
Hospitalizations 159 12,216
Average Patient Age 30.7 yrs 64.3 yrs
% Female Patients 7.1% 46.0%
FDA Approval Date N/A Aug 1, 2014
Manufacturer Genentech, Inc. Cardinal Health 107, LLC
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription